Open Tender for Cap Crizotinib 250 mg,Rituximab 100mg Inj,InjLeucovorin Calcium 50mg,5-Fluorouracil 500mg, 10 ml In in KOLKATA, WEST BENGAL
Bid Publish Date
18-Aug-2026, 9:39 am
Bid End Date
01-Sep-2026, 10:00 am
EMD
₹32,994
Location
Progress
A tender has been published for Indian Army Cap Crizotinib 250 mg, Rituximab 100mg Inj, InjLeucovorin Calcium 50mg, 5-Fluorouracil 500mg, 10 ml Inj, cabozantinib 40 mg, Tab Cabozantinib 60 mg, Inj Fosaprepitant 150 mg, Aprepitant 1 Cap 125 mg and 2 Cap 80 mg pack of 3, Cabazitaxel 60 mg inj, Tab Megestrol acetate 160 mg, Tegafur 15 mg Gimeracil 4. 3 mg ND Oteracil 11. 8 mg cap, Tegafur 20 mg Gimeracil 5. 8 mg ND Oteracil 15. 8 mg cap, Inj Bevacizumab 300 mg, Tab Netupitant 300 mg plus Palonosetron 0. 5 mg, Palonosetron 0. 25 mgperml, Inj, Gemcitabine 200mg Inj, Gemcitabine 1000mg Inj, Capecitabine 500 mg Tab, Tab Morphine CR 30 mg, Rituximab 500 mg Inj in KOLKATA, WEST BENGAL. Quantity: 86546 by. Submission Deadline: 01-09-2026 10: 00: 00. Check eligibility and apply.
Tender Data
Bid Details
Quantity
86546
Category
Cap Crizotinib 250 mg
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
RA Qualification Rule
H1-Highest Priced Bid Elimination
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
Yes
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Past Performance
20 %
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Cap Crizotinib 250 mg , Rituximab 100mg Inj , InjLeucovorin Calcium 50mg , 5-Fluorouracil 500mg, 10 ml Inj , cabozantinib 40 mg , Tab Cabozantinib 60 mg , Inj Fosaprepitant 150 mg , Aprepitant 1 Cap 125 mg and 2 Cap 80 mg pack of 3 , Cabazitaxel 60 mg inj , Tab Megestrol acetate 160 mg , Tegafur 15 mg Gimeracil 4.3 mg ND Oteracil 11.8 mg cap , Tegafur 20 mg Gimeracil 5.8 mg ND Oteracil 15.8 mg cap , Inj Bevacizumab 300 mg , Tab Netupitant 300 mg plus Palonosetron 0.5 mg , Palonosetron 0.25 mgperml, Inj , Gemcitabine 200mg Inj , Gemcitabine 1000mg Inj , Capecitabine 500 mg Tab , Tab Morphine CR 30 mg , Rituximab 500 mg Inj
Advisory Bank
State Bank of India
ePBG Percentage
5%
ePBG Duration (Months)
6
Delivery Details
Max Delivery Days
30
Delivery Locations
1
Delivery Cities
Kolkata
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | Kolkata | Kolkata | - | - | 1440 | 30 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-9678223.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
20 Items Sign in to view GEM price trends Sign in for GEM prices
Cap Crizotinib 250 mg
Cap Crizotinib 250 mg
Rituximab 100mg Inj
Rituximab 100mg Inj
InjLeucovorin Calcium 50mg
InjLeucovorin Calcium 50mg
5-Fluorouracil 500mg, 10 ml Inj
5-Fluorouracil 500mg, 10 ml Inj
cabozantinib 40 mg
cabozantinib 40 mg
Tab Cabozantinib 60 mg
Tab Cabozantinib 60 mg
Inj Fosaprepitant 150 mg
Inj Fosaprepitant 150 mg
Aprepitant 1 Cap 125 mg and 2 Cap 80 mg pack of 3
Aprepitant 1 Cap 125 mg & 2 Cap 80 mg pack of 3
Cabazitaxel 60 mg inj
Cabazitaxel 60 mg inj
Tab Megestrol acetate 160 mg
Tab Megestrol acetate 160 mg
Tegafur 15 mg Gimeracil 4.3 mg ND Oteracil 11.8 mg cap
Tegafur 15 mg Gimeracil 4.3 mg ND Oteracil 11.8 mg cap
Tegafur 20 mg Gimeracil 5.8 mg ND Oteracil 15.8 mg cap
Tegafur 20 mg Gimeracil 5.8 mg ND Oteracil 15.8 mg cap
Inj Bevacizumab 300 mg
Inj Bevacizumab 300 mg
Tab Netupitant 300 mg plus Palonosetron 0.5 mg
Tab Netupitant 300 mg + Palonosetron 0.5 mg
Palonosetron 0.25 mgperml, Inj
Palonosetron 0.25 mg/ml, Inj
Gemcitabine 200mg Inj
Gemcitabine 200mg Inj
Gemcitabine 1000mg Inj
Gemcitabine 1000mg Inj
Capecitabine 500 mg Tab
Capecitabine 500 mg Tab
Tab Morphine CR 30 mg
Tab Morphine CR 30 mg
Rituximab 500 mg Inj
Rituximab 500 mg Inj
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Cap Crizotinib 250 mg | Cap Crizotinib 250 mg | 1,440 | no | consignee2dglp | 30 | |
| 2 | Rituximab 100mg Inj | Rituximab 100mg Inj | 168 | amp or vial | consignee2dglp | 30 | |
| 3 | InjLeucovorin Calcium 50mg | InjLeucovorin Calcium 50mg | 1,120 | vial | consignee2dglp | 30 | |
| 4 | 5-Fluorouracil 500mg, 10 ml Inj | 5-Fluorouracil 500mg, 10 ml Inj | 1,800 | amp or vial | consignee2dglp | 30 | |
| 5 | cabozantinib 40 mg | cabozantinib 40 mg | 2,880 | nos | consignee2dglp | 30 | |
| 6 | Tab Cabozantinib 60 mg | Tab Cabozantinib 60 mg | 1,440 | nos | consignee2dglp | 30 | |
| 7 | Inj Fosaprepitant 150 mg | Inj Fosaprepitant 150 mg | 348 | vial | consignee2dglp | 30 | |
| 8 | Aprepitant 1 Cap 125 mg and 2 Cap 80 mg pack of 3 | Aprepitant 1 Cap 125 mg & 2 Cap 80 mg pack of 3 | 1,830 | no | consignee2dglp | 30 | |
| 9 | Cabazitaxel 60 mg inj | Cabazitaxel 60 mg inj | 60 | vials | consignee2dglp | 30 | |
| 10 | Tab Megestrol acetate 160 mg | Tab Megestrol acetate 160 mg | 11,200 | nos | consignee2dglp | 30 | |
| 11 | Tegafur 15 mg Gimeracil 4.3 mg ND Oteracil 11.8 mg cap | Tegafur 15 mg Gimeracil 4.3 mg ND Oteracil 11.8 mg cap | 600 | no | consignee2dglp | 30 | |
| 12 | Tegafur 20 mg Gimeracil 5.8 mg ND Oteracil 15.8 mg cap | Tegafur 20 mg Gimeracil 5.8 mg ND Oteracil 15.8 mg cap | 600 | no | consignee2dglp | 30 | |
| 13 | Inj Bevacizumab 300 mg | Inj Bevacizumab 300 mg | 600 | vial | consignee2dglp | 30 | |
| 14 | Tab Netupitant 300 mg plus Palonosetron 0.5 mg | Tab Netupitant 300 mg + Palonosetron 0.5 mg | 540 | nos | consignee2dglp | 30 | |
| 15 | Palonosetron 0.25 mgperml, Inj | Palonosetron 0.25 mg/ml, Inj | 5,400 | amp or vial | consignee2dglp | 30 | |
| 16 | Gemcitabine 200mg Inj | Gemcitabine 200mg Inj | 600 | vial | consignee2dglp | 30 | |
| 17 | Gemcitabine 1000mg Inj | Gemcitabine 1000mg Inj | 600 | vial | consignee2dglp | 30 | |
| 18 | Capecitabine 500 mg Tab | Capecitabine 500 mg Tab | 48,000 | no | consignee2dglp | 30 | |
| 19 | Tab Morphine CR 30 mg | Tab Morphine CR 30 mg | 7,100 | no | consignee2dglp | 30 | |
| 20 | Rituximab 500 mg Inj | Rituximab 500 mg Inj | 220 | amp or vial | consignee2dglp | 30 |
Categories
4
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer